Creso making progress across its Lifestyle cannabis portfolio
Creso Pharma Ltd (ASX:CPH) has advised the market that it is making good progress with its Lifestyle portfolio.
Progress was made across a number of fronts in August and this was acknowledged by investors with the company’s share price increasing circa 25% after negotiating an agreement to commercialise cannaQIX® in Austria and targeted Eastern and Northern European countries
Creso’s broader portfolio is designed with unique products to appeal to a diversified global consumer base.
In keeping with all of its product categories, therapeutics, nutraceuticals, animal health and topicals, Creso’s strategy with Lifestyle products is to identify and secure agreements with reputable commercial partners.
These partners provide market knowledge and the ability to launch and distribute products within an established network, allowing Creso to expand quickly across global markets.
Of course, Creso remains a speculative stock so investors should seek professional financial advice if considering this stock for their portfolio.
Cannabis infused beers gaining popularity
Within Creso’s Lifestyle portfolio, partnerships are being discussed across many of the key markets to develop and launch products.
Creso has progressed its joint venture with LGC Capital (LG:TSX.V) and the Baltic Beer Company - CLV Frontier Brands Pty Ltd - to bring innovative and relevant products to market quickly.
As consumers become more comfortable with the idea of cannabis-infused drinks, and following legalisation across some US states and in Canada, several of the global leaders in alcoholic beverages, including Molson Coors Brewing Co and Constellation Brands Inc. are investing heavily in developing cannabis-infused beverages.
Creso also said that another beverage giant, Diageo, is rumoured to be entering the field.
CLV joint venture provides global reach
CLV Frontier Brands will have wide-spread commercialisation reach across numerous continents and intends to make full use of the networks of all three companies for marketing and distribution, strictly in compliance with all local and international laws.
CLV is currently in discussions with distributors in Canada, where there is a large consumer base with an appetite for cannabis derived products and the view is that there will be enhanced demand in relation to the legislation of recreational cannabis in October 2018.
Branding for the range of Old Boy Mary Jane (OBMJ) beers has been finished and samples have been sent to Europe, Israel and Australia.
The brand website, www.obmj.beer CLV Frontier Brands is available and will formally launch its premium beers in the United Kingdom on October 2, 2018 in conjunction with the London Boutique Bar Show (www.boutiquebarshow.com) which exclusively promotes new and high-quality drinks brands to the UK industry.
CLV Frontier Brands beverages create a world of new products that deliver a uniquely enjoyable drinking experience.
Initiatives such as social media campaigns are being run to ensure organic growth and awareness for the Old Boy Mary Jane brand.
CLV Frontier Brands will partner with Flagship Brands in the UK who understand the UK market and are well respected having worked with various alcoholic drinks brands over the years.
CLV will also launch OBMJ at the key beer show Bar Convent Berlin (www.barconvent.com/de) between October 8 and October 10, providing extensive exposure to the European bar scene.
Launch of cannabis infused foods
In tandem with its strong progress on the beverages front, Creso has been laying the foundations for a December quarter launch of cannabis infused food products.
The high-growth functional foods space provides lucrative opportunities for more cannabis-infused products.
In partnership with Felchlin Switzerland, Creso’s terpene-enriched functional MÒÁ line of chocolate brands is now in the hands of numerous businesses globally with the aim of bringing products to market by the December quarter of 2018.
Felchlin is a high end genuine Swiss chocolate producer and operates in line with Creso’s quality standards.
Discussing Creso’s achievements in terms of developing diversified products that can be distributed in multiple global markets, chief executive and founder, Dr. Miri Halperin Wernli said, “Creso has seen the potential for cannabis-enriched food and beverages.
“We are in the process of discussing agreements with partners to enter this market in countries across the world.
“Big beverage companies have seen the opportunity as consumer appetites grow for products infused with cannabis and enhanced with terpenes.
“Creso, with its established presence in the US and Canada, where the biggest potential currently lies, is perfectly positioned for its products to become a leader in this new and emerging field.”
Creso continues to identify and secure agreements with experienced commercial partners across Europe, Israel, Australia and the Americas, further expanding the global reach of its Lifestyle products to increase the overall success and reach of all Creso owned brands.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.